1[1]Haffner Sn,Coazalez C,Uietnen H,et al.A prospective analysis of the Home mode[J].Diabetetes care 1996;19(10):1138-1141.
2[2]Fuhlendorff J Molecular identification of a specific binding site (36Kda)for repaglinide[J].Diabetes 1998;47:416-502.
3[3]Landgaf R.Bilo HJG Repaglinide vs glibendamide:a 14-weekefficacy and safety comparison[J].Diabetologia 1997;40(Suppl,1):321-326.
4[4]Moss R.A review of clinical expericrlce with the prandial glucose regulator.reaglinide,in the treatment of type 2 diabetes[J].Exert Opin harma Cother 2000;1:1455-1467.
9Qian L,Zhang S,Xu L,et al.Endoplasmic reticulum stress in cells:Latent mechanism of secondary sulfonylurea failure in type 2 diabetes?[J].Med Hypotheses,2008,71 (6):889-891.
10UK.Prospective Diabetes Study Group,UK prospective diabetes study 16:overview of 6 years' therapy of type 2 diahetes:a progressive disease[J].Diabetes,1995,44(11):1249-1258.
